Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice.
Peroxisome proliferator chemicals, acting via the peroxisome proliferator-activated receptor-alpha (Pparalpha), are potent hepatic mitogens and carcinogens in mice and rats. To test whether Pparalpha is required for hepatic growth in response to other stimuli, we studied liver regeneration and hepatic gene expression following partial hepatectomy (PH) of wild-type and Pparalpha-null mice. Pparalpha-null mice had a 12- to 24-hour delay in liver regeneration associated with a delayed onset and lower peak magnitude of hepatocellular DNA synthesis. Furthermore, these mice had a 24-hour lag in the hepatic expression of the G(1)/S checkpoint regulator genes Ccnd1 and cMyc and increased expression of the IL-1beta cytokine gene. Hepatic expression of Ccnd1, cMyc, IL-1r1, and IL-6r was induced in wild-type mice, but not Pparalpha-null mice, after acute exposure to the potent Pparalpha agonist Wy-14,643, indicating a role for Pparalpha in regulating the expression of these genes. Expression of the fatty acid omega-hydroxylase gene Cyp4a14, a commonly used indicator gene for Pparalpha activation, was strongly induced in wild-type mice after hepatectomy, suggesting that altered hepatocyte lipid processing may also contribute to the impaired regeneration in mice lacking the Pparalpha gene. In conclusion, liver regeneration in Pparalpha-null mice is transiently impaired and is associated with altered expression of genes involved in cell cycle control, cytokine signaling, and fat metabolism.
Toxicogenomics Group, GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA. spa88482@gsk.com
Steven P
SP
Anderson
Lawrence
L
Yoon
Erika B
EB
Richard
Corrie S
CS
Dunn
Russell C
RC
Cattley
J Christopher
JC
Corton
D000818:Animals; D019938:Cyclin D1 / Q000235:genetics; D016193:G1 Phase / Q000235:genetics; D015870:Gene Expression / Q000502:physiology; D005819:Genetic Markers; D006498:Hepatectomy; D007375:Interleukin-1 / Q000235:genetics; D008099:Liver / Q000166:cytology / Q000502:physiology*; D008115:Liver Regeneration / Q000235:genetics*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics*; D017472:Receptors, Interleukin-1 / Q000235:genetics; D053573:Receptors, Interleukin-1 Type I; D019947:Receptors, Interleukin-6 / Q000235:genetics; D016192:Resting Phase, Cell Cycle / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics*
D005819:Genetic Markers; D007375:Interleukin-1; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; D017472:Receptors, Interleukin-1; D053573:Receptors, Interleukin-1 Type I; D019947:Receptors, Interleukin-6; D014157:Transcription Factors; D019938:Cyclin D1